VarsaAI Partners with GW Health to Add Senior Strategic Communications Expertise to Its Platform Offering

VarsaAI today announced a formal partnership with GW Health, a senior-led strategic communications agency serving pharmaceutical, biotechnology, and life sciences organizations. Announced at the Cannes Lions Festival, the collaboration extends VarsaAI beyond software — adding senior communications expertise, strategic consultancy, and hands-on change management to the platform offering.

This partnership reflects a deliberate shift in how VarsaAI shows up for its customers. The platform already compresses mechanism-of-action (MOA) and mechanism-of-disease (MOD) production from weeks to minutes. With GW Health as VarsaAI's strategic MOA development partner, customers now have direct access to senior-led communications guidance to make sure that speed is matched with strategic intent, narrative quality, and launch-grade impact.

Expert Services and Consultancy, Built Into the VarsaAI Offering

Pharma organizations adopting AI rarely fail because the technology underperforms. They stall because internal workflows, review models, and content governance were designed for a 12-week cycle, not a 12-minute one. Redesigning that operating model is a change management problem before it is a technology problem.

Through this partnership, VarsaAI customers gain access to GW Health's senior strategists to support exactly that redesign — from how MOA content fits into a launch narrative or disease education campaign, to how teams structure briefs, MLR review, and creative oversight in an AI-native workflow. The result is a single offering that pairs the speed and compliance of the VarsaAI platform with the strategic depth required to embed it inside a regulated, enterprise environment.

"Our customers are not just buying a faster way to produce MOA content. They are redesigning how their organization moves science to audience," said Florence Holliday, Co-founder and Chief Science Officer of VarsaAI. "Adding GW Health's senior strategic expertise to our offering means customers get the platform, the playbook, and the partner needed to make that shift stick."

Change Management for AI-Native Content Workflows

Mechanism-of-action content sits at the center of product launches, congress booths, disease education, and professional engagement. Traditional production involves multiple agency partners, lengthy development cycles, and costs that delay time-sensitive communications. Compressing that cycle to minutes translates directly into reduced agency fees, fewer revision rounds, and faster time to market at critical milestones.

But unlocking that value requires more than software. It requires re-engineering the workflow around it. GW Health's senior team works alongside VarsaAI customers to navigate that change — aligning Medical, Marketing, MLR, and agency partners around a faster, AI-native operating model that holds up under regulatory scrutiny.

VarsaAI's patent-pending VeriCore™ scientific verification system, sentence-level referencing, and full medical, legal, and regulatory (MLR) audit trail were built specifically for the standards required in regulated healthcare communications. Combined with GW Health's strategic communications expertise, customers can move from scientific concept to compliant, audience-ready content faster than anything currently available in the market — without losing strategic control of the narrative.

"Today's life sciences companies face increasing pressure to move complex science from lab to audience faster, without sacrificing accuracy or impact. Our partnership with VarsaAI meets that challenge directly. It pairs strategic communications leadership and creativity with technology built specifically for the realities of our industry," said Aleisia Gibson Wright, Founder and President of GW Health.

About GW Health

GW Health is a senior-led strategic communications agency serving pharmaceutical, biotechnology, and life sciences organizations across the full product lifecycle. Founded by Aleisia Gibson Wright, a PRWeek Top 30 Health Influencer with more than 25 years of healthcare communications experience, the agency helps organizations transform complex science into meaningful engagement through audience-centered strategies grounded in clarity, connection, and action. GW Health's expertise spans more than 15 therapeutic categories and is strengthened through strategic partnerships.

About VarsaAI

VarsaAI is the AI scientific content platform built specifically for pharmaceutical, biotechnology, and medical affairs teams. The platform enables organizations to create scientifically verified MOA videos, presentations, and PDFs in minutes while maintaining full intellectual property ownership. Its patent-pending VeriCore™ scientific verification technology and MLR-ready audit trail help organizations accelerate scientific communications while meeting the standards required in regulated healthcare environments.